XBP1 and inflammatory bowel disease: Our results confirm previous research indicating that activation of the ATF6, IRE and PERK signaling branches is seen in patients with colonic IBD [10], and are also consistent with data from mice with conditional deletion of XBP-1 in the intestinal epithelium [9].